Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Olfactory Mucosa-derived MSCs for Laryngotracheal Stenosis
NCT03130374Phase 2Completed
- Sponsor
- Republican Research and Practical Center for Epidemiology and Microbiology
- Start
- Jan 2017
- Primary completion
- Jan 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous olfactory mucosa-derived mesenchymal stem cells in laryngeal stenosis (LTS), tracheal stenosis (TS), sponsored by Republican Research and Practical Center for Epidemiology and Microbiology. Started Jan 2017; status: completed.
02
Drugs
autologous olfactory mucosa-derived mesenchymal stem cells
03
Conditions
laryngeal stenosis (LTS)tracheal stenosis (TS)
Beyond the preview
Go deeper on NCT03130374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03130374.